How many 8-K filings has Cytodyn Inc. filed?

Cytodyn Inc. (CYDY) has 13 8-K (Current Event Report) filings on record, spanning Jan 2024 to Mar 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Cytodyn Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Cytodyn Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Cytodyn Inc. (CYDY) — 8-K Filings

All 8-K filings from Cytodyn Inc.. Browse 13 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (13)

CytoDyn Files 8-K on Material Definitive Agreement — Mar 24, 2026
CytoDyn Inc. filed an 8-K on March 24, 2026, indicating an "Entry into a Material Definitive Agreement" under Item 1.01. While the specific details of the agree
CytoDyn Inc. Files 8-K Current Report — Dec 1, 2025 Risk: low
CytoDyn Inc. filed an 8-K on November 23, 2025, reporting other events. The company, incorporated in Delaware, is located at 1111 Main Street, Suite 660, Vancou
CytoDyn Inc. Files 8-K with Corporate Updates — Nov 21, 2025 Risk: medium
CytoDyn Inc. filed an 8-K on November 21, 2025, reporting on several key corporate events. These include amendments to its articles of incorporation or bylaws,
CytoDyn Inc. Reports Change in Certifying Accountant — May 16, 2025 Risk: medium
CytoDyn Inc. filed an 8-K on May 16, 2025, reporting a change in its certifying accountant. The company, incorporated in Delaware with its principal executive o
CytoDyn Inc. Files 8-K on Officer/Director Changes — May 6, 2025 Risk: medium
CytoDyn Inc. filed an 8-K on May 6, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain off
CytoDyn Inc. Files 8-K on Shareholder Votes — Nov 22, 2024 Risk: low
CytoDyn Inc. filed an 8-K on November 22, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's corporate str
CytoDyn Inc. Files 8-K with Regulatory Updates — Jul 9, 2024 Risk: medium
CytoDyn Inc. filed an 8-K on July 9, 2024, reporting on events that occurred on July 2, 2024. The filing includes information related to Regulation FD Disclosur
CytoDyn Inc. Changes Independent Auditors — Jun 28, 2024 Risk: medium
CytoDyn Inc. announced on June 28, 2024, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting
CytoDyn Inc. Issues 1M Shares for Services — Jun 3, 2024 Risk: medium
On May 28, 2024, CytoDyn Inc. reported unregistered sales of equity securities. The company issued 1,000,000 shares of common stock to a consultant in exchange
CytoDyn Inc. Dismisses Auditor Malone Bailey LLP — May 6, 2024 Risk: medium
CytoDyn Inc. announced on May 6, 2024, that it has dismissed its independent registered public accounting firm, MaloneBailey LLP. The company has not yet appoin
CytoDyn Inc. Terminates Material Definitive Agreement — Apr 8, 2024 Risk: medium
CytoDyn Inc. announced on April 3, 2024, the termination of a material definitive agreement. The company, incorporated in Delaware, is based in Vancouver, Washi
CytoDyn Inc. Reports Unregistered Equity Sales — Mar 28, 2024 Risk: medium
CytoDyn Inc. filed an 8-K on March 28, 2024, reporting unregistered sales of equity securities on March 22, 2024. The filing does not disclose specific details
CytoDyn Files Routine 8-K; No New Material Events Reported — Jan 29, 2024
CytoDyn Inc. filed an 8-K on January 29, 2024, reporting no new material events. The filing simply re-states the company's basic information, such as its addres

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX